Physician

Robert P Young, M.D.

According to 2025 Medicare claims, Robert Young, M.D. (NPI: 1013910744) practices dermatology in the Logan, UT-ID market, with the plurality of this provider's patient population coming from Cache, UT. This provider's primary affiliated billing organization is ROCKY MOUNTAIN DERMATOLOGY INC (NPI: 1154527372; TIN: 870625774) and primary practice location at 84341-1202.

Young's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 763 traditional Medicare patients, billed 3,987 HCPCS/CPT codes, and received $162,133 in Medicare payments. The top billing code was 11102 (Biopsy of related skin growth, first growth). Part D data shows 256 prescription claims across 136 beneficiaries totaling $10,230 in drug costs, led by Fluorouracil (Fluorouracil). Open Payments data shows 15 records totaling $301. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing started with an early spike, then settled into a lower baseline, moving from $372,479 to $162,133. In contrast, Part D prescription costs have moved sharply higher in recent years, from $7,293 to $10,230. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$186K$372K2015 Medicare payment: $372,479 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $316,550 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $288,323 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $133,926 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $264,886 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $54,890 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $122,674 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $117,882 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $95,211 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $162,133 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,0689,645$372,479
20161,0408,457$316,550
20171,0657,919$288,323
20181,0244,336$133,926
20191,0284,168$264,886
20207932,108$54,890
20219213,459$122,674
20228833,447$117,882
20238653,312$95,211
20247633,987$162,133

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$6.1K$12K2015 Drug cost: $7,293 (USD; Tot_Drug_Cst)2016 Drug cost: $5,444 (USD; Tot_Drug_Cst)2017 Drug cost: $5,055 (USD; Tot_Drug_Cst)2018 Drug cost: $3,958 (USD; Tot_Drug_Cst)2019 Drug cost: $1,496 (USD; Tot_Drug_Cst)2020 Drug cost: $2,808 (USD; Tot_Drug_Cst)2021 Drug cost: $3,769 (USD; Tot_Drug_Cst)2022 Drug cost: $4,450 (USD; Tot_Drug_Cst)2023 Drug cost: $12,146 (USD; Tot_Drug_Cst)2024 Drug cost: $10,230 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20154083$7,293
20163998$5,444
20174599$5,055
20183375$3,958
20192741$1,496
20203369$2,808
202171129$3,769
202288136$4,450
2023107185$12,146
2024136256$10,230

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
11102Biopsy of related skin growth, first growth148179$66
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more224292$59
17000Destruction of precancer skin growth, 1 growth176207$31
88305Pathology examination of tissue using a microscope, intermediate complexity6131,101$22
17003Destruction of precancer skin growth, 2-14 growths150968$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
FluorouracilFluorouracil29855$2,445
Doxycycline MonohydrateDoxycycline Monohydrate14540$839
Clobetasol PropionateClobetasol Propionate23765$653
Triamcinolone AcetonideTriamcinolone Acetonide371,270$368
PermethrinPermethrin11276$262

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.15$301ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Robert P. Young, M.D.?

Tedicare shows public-source Medicare data for Robert P. Young, M.D. (NPI 1013910744), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Robert P. Young, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Robert P. Young, M.D.?

Robert P. Young, M.D. is linked to ROCKY MOUNTAIN DERMATOLOGY INC (billing NPI 1154527372) in the available physician profile data.

Does Robert P. Young, M.D. have Open Payments data?

Robert P. Young, M.D. has 15 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.